Company Profile
VBI Vaccines Stock Price, News & Analysis
- Ticker:
- VBIV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for VBIV.
Company overview
Business overview
VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, VBI Vaccines is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts.
Business Model Characteristics
VBI Vaccines combines program development with demand-sensitive launch execution, so investors usually track efficacy, safety, and the commercial path for each major asset.
Position Within the Biotechnology Landscape
Compared with broader biotech peers, VBI Vaccines sits in a catalyst-heavy corner of the landscape where virus, vaccine, and antiviral updates can move sentiment quickly.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does VBI Vaccines do?
VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
On which exchange is VBIV stock listed?
VBI Vaccines (VBIV) is associated with NASDAQ, United States, Biopharma.
What is Vaccines?
VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
Which conditions is VBI Vaccines targeting with Vaccines?
VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.